The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis
Open accessAbstract
During atherogenesis, LDL is oxidized, generating various oxidation-specific neoepitopes, such as malondialdehyde-modified (MDA-modified) LDL (MDA-LDL) or the phosphorylcholine (PC) headgroup of oxidized phospholipids (OxPLs).These epitopes are recognized by both adaptive T cell-dependent (TD) and innate T cell-independent type 2 (TI-2) immune responses.We previously showed that immunization of mice with MDA-LDL induces a TD response and atheroprotection.In addition, a PC-based immunization strategy that leads to a TI-2 expansion of innate B-1 cells and secretion of T15/EO6 clonotype natural IgM antibodies, which bind the PC of OxPLs within oxidized LDL (OxLDL), also reduces atherogenesis.T15/EO6 antibodies inhibit OxLDL uptake by macrophages.We now report that immunization with MDA-LDL, which does not contain OxPL, unexpectedly led to the expansion of T15/EO6 antibodies.MDA-LDL immunization caused a preferential expansion of MDA-LDL-specific Th2 cells that prominently secreted IL-5.In turn, IL-5 provided noncognate stimulation to innate B-1 cells, leading to increased secretion of T15/EO6 IgM.Using a bone marrow transplant model, we also demonstrated that IL-5 deficiency led to decreased titers of T15/EO6 and accelerated atherosclerosis.Thus, IL-5 links adaptive and natural immunity specific to epitopes of OxLDL and protects from atherosclerosis, in part by stimulating the expansion of atheroprotective natural IgM specific for OxLDL.Nonstandard abbreviations used: alkaline phosphatase (AP); bone marrow transplantation (BMT); fast-performance liquid chromatography (FPLC); immune complex (IC); LDL receptor (LDLR); malondialdehyde (MDA); MDA-modified LDL (MDA-LDL); oxidized LDL (OxLDL); oxidized phospholipid (OxPL); 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine (POVPC); phosphorylcholine (PC); relative light units (RLU); T cell-dependent (TD); T cell-independent (TI); T cellindependent type 2 (TI-2). Conflict of interest:The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Self-citationLow density lipoprotein undergoes oxidative modification in vivo.
Palinski, W., Rosenfeld, M. E., Ylä-Herttuala, S., Gurtner, G. C., Socher, S. S., Butler, S. W., Parthasarathy, S., Carew, T. E., Steinberg, D., & Witztum, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1372 · Cited by 1,519
Self-citationInnate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Immune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Li, A. C., Brown, K. K., Silvestre, M. J., Willson, T. M., Palinski, W., & Glass, C. K. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10370 · Cited by 833
Self-citationProtective Role of Interleukin-10 in Atherosclerosis
Mallat, Z., Besnard, S., Duriez, M., Deleuze, V., Emmanuel, F., Bureau, M. F., Soubrier, F., Esposito, B., Duez, H., Fievet, C., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.8.e17 · Cited by 831
Origins and Functions of B-1 Cells with Notes on the Role of CD5
Berland, R., & Wortis, H. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064833 · Cited by 745
Binder, C. J., Hörkkö, S., Dewan, A., Chang, M.-K., Kieu, E. P., Goodyear, C. S., Shaw, P. X., Palinski, W., Witztum, J. L., & Silverman, G. J. (2003) · Nature Medicine · doi:10.1038/nm876 · Cited by 737
Self-citationAtherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
Steinberg, D. (2002) · Nature Medicine · doi:10.1038/nm1102-1211 · Cited by 679
Shaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Self-citationInnate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Self-citationModes of action of Freund's adjuvants in experimental models of autoimmune diseases
Billiau, A., & Matthys, P. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.849 · Cited by 617
Yamaguchi, Y., Hayashi, Y., Sugama, Y., Miura, Y., Kasahara, T., Kitamura, S., Torisu, M., Mita, S., Tominaga, A., & Takatsu, K. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.5.1737 · Cited by 608
Kopf, M., Brombacher, F., Hodgkin, P. D., Ramsay, A. J., Milbourne, E. A., Dai, W. J., Ovington, K. S., Behm, C. A., Köhler, G., Young, I. G., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80294-0 · Cited by 594
Palinski, W., Miller, E., & Witztum, J. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.821 · Cited by 590
Self-citationHörkkö, S., Bird, D. A., Miller, E., Itabe, H., Leitinger, N., Subbanagounder, G., Berliner, J. A., Friedman, P., Dennis, E. A., Curtiss, L. K., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4533 · Cited by 559
Self-citationPalinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Self-citationProtective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice
Caligiuri, G., Nicoletti, A., Poirier, B., & Hansson, G. K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci7272 · Cited by 530
Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10
O'garra, A., Chang, R., Go, N., Hastings, R., Haughton, G., & Howard, M. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220314 · Cited by 526
Immune mechanisms in atherosclerosis.
Hansson, G. K., Jonasson, L., Seifert, P. S., & Stemme, S. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.567 · Cited by 515
Tangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Self-citationYamaguchi, Y., Suda, T., Suda, J., Eguchi, M., Miura, Y., Harada, N., Tominaga, A., & Takatsu, K. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.1.43 · Cited by 514
Palinski, W., Ord, V. A., Plump, A. S., Breslow, J. L., Steinberg, D., & Witztum, J. L. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.4.605 · Cited by 488
Self-citationChang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K.-H., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 459
Self-citationDavenport, P., & Tipping, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 444
Autoreactivity by design: innate B and T lymphocytes
Bendelac, A., Bonneville, M., & Kearney, J. F. (2001) · Nature Reviews Immunology · doi:10.1038/35105052 · Cited by 416
Zhou, X., Paulsson, G., Stemme, S., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1216 · Cited by 413
Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., Cheroutre, H., Curtiss, L. K., Berliner, J. A., & Boisvert, W. A. (2002) · Circulation Research · doi:10.1161/01.res.0000018941.10726.fa · Cited by 356
Self-citationB-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice
Major, A. S., Fazio, S., & Linton, M. F. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000039169.47943.ee · Cited by 329
Freigang, S., Hörkkö, S., Miller, E., Witztum, J. L., & Palinski, W. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.12.1972 · Cited by 315
Self-citationThe Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Briles, D. E., Forman, C., Hudak, S., & Claflin, J. L. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.4.1177 · Cited by 310
Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., & Kanai, Y. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.429 · Cited by 298
LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis
Zhou, X., Caligiuri, G., Hamsten, A., Lefvert, A. K., & Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.108 · Cited by 290
George, J., Afek, A., Gilburd, B., Levkovitz, H., Shaish, A., Goldberg, I., Kopolovic, Y., Wick, G., Shoenfeld, Y., & Harats, D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00015-x · Cited by 267
King, V. L., Szilvassy, S. J., & Daugherty, A. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.104905 · Cited by 265
Lymphocytes are important in early atherosclerosis
Song, L., Leung, C. C., & Schindler, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11380 · Cited by 249
Palinski, W., Tangirala, R. K., Miller, E., Young, S. G., & Witztum, J. L. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1569 · Cited by 239
Self-citationTH2 Predominant Immune Responses Prevail in Human Abdominal Aortic Aneurysm
Schönbeck, U., Sukhova, G. K., Gerdes, N., & Libby, P. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64206-x · Cited by 216
Zhou, J., Møller, J., Danielsen, C. C., Bentzon, J., Ravn, H. B., Austin, R. C., & Falk, E. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.096582 · Cited by 216
Yoshida, T., Ikuta, K., Sugaya, H., Maki, K., Takagi, M., Kanazawa, H., Sunaga, S., Kinashi, T., Yoshimura, K., Miyazaki, J.-I., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80414-8 · Cited by 214
Huber, S. A., Sakkinen, P., David, C., Newell, M. K., & Tracy, R. P. (2001) · Circulation · doi:10.1161/01.cir.103.21.2610 · Cited by 211
Ishida, H., Hastings, R., Kearney, J., & Howard, M. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1213 · Cited by 196
Friedman, P., Hörkkö, S., Steinberg, D., Witztum, J. L., & Dennis, E. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108860200 · Cited by 195
Self-citationIFN- γ Deficiency Exerts Gender-Specific Effects on Atherogenesis in Apolipoprotein E -/- Mice
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100141 · Cited by 176
Immunological responses to oxidized LDL
Hörkkö, S., Binder, C. J., Shaw, P. X., Chang, M.-K., Silverman, G., Palinski, W., & Witztum, J. L. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00333-6 · Cited by 172
Self-citationPhosphorylcholine: friend or foe of the immune system?
Harnett, W., & Harnett, M. M. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01419-4 · Cited by 167
B-1 Cells: unique origins and functions
Stall, A. M., Wells, S. M., & Lam, K. (1996) · Seminars in Immunology · doi:10.1006/smim.1996.0007 · Cited by 126
Interleukin 5 and B cell differentiation
Takatsu, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00034-8 · Cited by 125
Schiller, N. K., Kubo, N., Boisvert, W. A., & Curtiss, L. K. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096724 · Cited by 108
Self-citationNisitani, S., Tsubata, T., Murakami, M., & Honjo, T. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251110 · Cited by 81
Anti-Interleukin-5 Monoclonal Antibodies: Preclinical and Clinical Evidence in Asthma Models
Leckie, M. J. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256653 · Cited by 79
Murine B1 B Cells Require IL-5 for Optimal T Cell-Dependent Activation
Erickson, L. D., Foy, T. M., & Waldschmidt, T. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.1531 · Cited by 76
Severe Hypercholesterolaemia Leads to Strong Th2 Responses to an Exogenous Antigen
Robertson, A.-K., Zhou, X., Strandvik, B., & Hansson, G. K. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01403.x · Cited by 62
Establishment of IL-5-Dependent Early B Cell Lines by Long-Term Bone Marrow Cultures
Tominaga, A., Mita, S., Kikuchi, Y., Hitoshi, Y., Takatsu, K., Nishikawa, S., & Ogawa, M. (1989) · Growth Factors · doi:10.3109/08977198909029123 · Cited by 60
Immune recognition of OxLDL in atherosclerosis
Kearney, J. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10426 · Cited by 51
Inhibition of murine B1 lymphocytes by interleukin‐12
Vogel, L. A., Lester, T. L., Cleave, V. H. V., & Metzger, D. W. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260134 · Cited by 38
Inhibition of interleukin‐5 with a monoclonal antibody attenuates allergic inflammation
Danzig, M., & Cuss, F. M. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb02149.x · Cited by 34
Zlot, C. H., Flynn, L. M., Véniant, M. M., Kim, E., Raabe, M., McCormick, S. P. A., Ambroziak, P., McEvoy, L. M., & Young, S. G. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33341-1 · Cited by 22
Cited by
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
“Whereas the role of Th2 in atherosclerosis is controversial,(27-30) some, but not all, evidence suggests that Th2-slanted responses may drive aneurysm formation.”
BackgroundAtherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Metadata
- Authors
- Binder, C. J., Hartvigsen, K., Chang, M.-K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., & Witztum, J. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-08-01
- Volume
- 114
- Issue
- 3
- Pages
- 427-437
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2126873224
- Cited by
- 452
- References
- 61
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.